Ordinary Adjustment | Solactive Obesity Index (SLIMID) | January 2019

In the ordinary rebalance, the following composition will be implemented:

MICROPORT SCIENTIFIC CORP
LIFETECH SCIENTIFIC CORP
APEX BIOTECHNOLOGY CORP
TAIDOC TECHNOLOGY CORP
NIPRO (NISSHO) CORP ORD
ABIOMED INC
ANGIODYNAMICS INC
ARENA PHARMACEUTICALS INC
N BROWN GROUP PLC
CATO CORP-CLASS A
CRYOLIFE INC
CARDIOVASCULAR SYSTEMS INC
COHBAR INC
DAVITA INC
DEXCOM INC
DESTINATION XL GROUP INC
ESPERION THERAPEUTICS INC
FRESENIUS MEDICAL CARE AG & CO KGAA
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
HERBALIFE NUTRITION LTD
IRHYTHM TECHNOLOGIES INC
ITAMAR MEDICAL LTD
LEMAITRE VASCULAR INC
LEXICON PHARMACEUTICALS INC
MADRIGAL PHARMACEUTICALS INC
MEDIFAST INC
MANNKIND CORP
NOVO NORDISK AS CLASS B
NUTRISYSTEM INC.
NXSTAGE MEDICAL INC
INSULET CORP
POXEL SA
RESMED INC-CDI
ROCKWELL MEDICAL INC
RHYTHM PHARMACEUTICALS INC
SENSEONICS HOLDINGS INC
TANDEM DIABETES CARE INC
USANA HEALTH SCIENCES INC
WEIGHT WATCHERS INTL INC
ZAFGEN INC
EKF DIAGNOSTICS HOLDINGS PLC